Anebulo Pharmaceuticals, Inc. (ANEB)
Automate Your Wheel Strategy on ANEB
With Tiblio's Option Bot, you can configure your own wheel strategy including ANEB - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol ANEB
- Rev/Share 0.0
- Book/Share 0.1932
- PB 2.4486
- Debt/Equity 0.0
- CurrentRatio 16.7136
- ROIC -1.0266
- MktCap 19291178.0
- FreeCF/Share -0.1422
- PFCF -3.3032
- PE -2.4356
- Debt/Assets 0.0
- DivYield 0
- ROE -0.7458
- Rating C
- Score 2
- Recommendation Sell
- P/E Score 1
- DCF Score 4
- P/B Score 2
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| No ratings available. | |||||||
News
Anebulo Pharmaceuticals Announces Its Intent to Commence a Self Tender Offer
Published: December 22, 2025 by: Business Wire
Sentiment: Neutral
AUSTIN, Texas--(BUSINESS WIRE)--Anebulo Pharmaceuticals, Inc. (Nasdaq: ANEB), a clinical-stage pharmaceutical company developing novel solutions for people suffering from acute cannabis-induced toxic effects (the “Company” or “Anebulo”), today announced that the Board of Directors has decided to commence a cash tender offer as part of its plan to “go private” in lieu of the previously announced reverse stock split at a ratio of not less than 1-for-2,500 and not greater than 1-for-7,500. Volunta.
Read More
About Anebulo Pharmaceuticals, Inc. (ANEB)
- IPO Date 2021-05-07
- Website https://www.anebulo.com
- Industry Biotechnology
- CEO Richard Anthony Cunningham
- Employees 2